SPECIAL ARTICLE
OPEN ACCESS ‑ PEER‑REVIEWED
|
After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac SurgeryDOI: 10.21470/1678-9741-2021-0955 Publish in: August 3 2025 How to cite this articleEvora PRB, Soares ROS, Bassetto S, Auxiliadora-Martins M, Silva FLS, Basile A. After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery. Braz J Cardiovasc Surg. 2021;36(3):406-411 |